Aerie raises $67.2 million in IPO

Aerie Pharmaceuticals Inc. (NASDAQ:AERI) raised $67.2 million in an IPO through the sale of a bumped-up number of shares below the company's proposed range. The ophthalmic company sold 6.7 million shares at $10, which values Aerie at $217.9 million. Earlier this month, the company amended the offering and said it planned to sell 5.3 million shares at $12-$14. RBC Capital Markets; Stifel; Canaccord; and Needham are underwriters. Aerie filed to raise up to $57.5 million in an IPO in September. The company was up $0.61 to $10.61 in its first day of trading on Friday. ...